Editor’s Note: This article is part of Joanna’s Top Trades — a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week is Zoom (NASDAQ:ZM) as the top stock to trade this week. We all know video-calling software maker Zoom (NASDAQ:ZM). The pandemic high-flier capitalized on a stay-at-home workforce, growing
0 Comments
Goldman Sachs has boosted its oil price target to $90, citing the lingering impact of Hurricane Ida on supply while demand ramps up, particularly in COVID-averse Asia. Analysts led by Damien Courvalin lifted their year-end forecast on Brent crude-oil to $90 from $80. Hurricane Ida should prove to be the most bullish hurricane in U.S.
0 Comments
Tesla CEO Elon Musk gestures as he visits the construction site of Tesla’s Gigafactory in Gruenheide near Berlin, Germany, August 13, 2021. Patrick Pleul | Reuters Though the market has been volatile, analysts are spotting opportunities for upside among select companies. Tipranks is able to cut through the market noise by aggregating data to show
0 Comments
Mexico is a classic example of a two-sided economy. While one part shines bright with a trillion-dollar gross domestic product, the other is gripped in darkness with more than 50% of its population living below the poverty line. Mexico has the second highest degree of socioeconomic disparity amongst the 34 member nations of the Organisation
0 Comments
Restaurant stocks have had a challenging couple of years now. The U.S. economy was almost on full throttle earlier this year, nearly hitting escape velocity from the pandemic. But things turned around as the year progressed. Now we sit on variety of conflicting economic indicators — some encouraging, other flashing warning signs. And so, while
0 Comments
Sesen Bio (NASDAQ:SESN) is a small biotech company attempting to develop a drug it calls Vicineum. SESN stock plunged last month after hitting a massive regulatory setback. Source: luchschenF / Shutterstock.com Sesen’s Vicineum aims to treat unresponsive non-muscle invasive bladder cancer using a locally administered recombinant fusion protein method. However, the Food and Drug Administration
0 Comments